title: Transformation of human glioma cell lines with the p16 gene inhibits cell proliferation.
abstract: We examined the genomic status of the p16 gene in 5 human glioma cell lines by Southern blot analysis. The p16 gene was located in the 9p21 chromosomal region and homozygous deletion was detected in 4 of 5 (80%) human glioma cell lines and 5 of 15 (33%) clinical samples. We transfected the full-length human p16 gene into p16-null human glioma cell line, U251MG cells, using the plasmid vector pRc/CMV-p16 and evaluated the effect of p16 gene transfer on the growth suppression of malignant glioma cells. The transfection of p16 cDNA caused growth suppression through G1 cell cycle arrest in U251MG cells. We also examined the effect of p16 gene transfer on the chemosensitivity to cis-diamminedichloroplatinum II (CDDP), 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl) -3-nitrosourea hydrochloride (ACNU), and 5'-azacytidine (AZC). We did not detect any change in them after p16 gene transfer. These results might suggest that deletion of p16 genes promoted unrestrained growth in human glioma but has no relationship to the chemosensitivity to CDDP, ACNU and AZC.
authors.affiliation: Department of Neurosurgery, Hiroshima University School of Medicine, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Hama
authors.forename: T
authors.initials: T
authors.lastname: Sadatomo
authors.forename: H
authors.initials: H
authors.lastname: Yoshioka
authors.forename: K
authors.initials: K
authors.lastname: Kurisu
authors.forename: E
authors.initials: E
authors.lastname: Tahara
authors.forename: I
authors.initials: I
authors.lastname: Naruse
authors.forename: Y
authors.initials: Y
authors.lastname: Heike
authors.forename: N
authors.initials: N
authors.lastname: Saijo
mesh_terms: D000970:Antineoplastic Agents / Q000633:toxicity*; D001374:Azacitidine / Q000633:toxicity; D001932:Brain Neoplasms / Q000235:genetics* / Q000473:pathology; D002352:Carrier Proteins / Q000096:biosynthesis* / Q000235:genetics; D002455:Cell Division; D002470:Cell Survival / Q000187:drug effects; D002874:Chromosome Mapping; D002899:Chromosomes, Human, Pair 9; D002945:Cisplatin / Q000633:toxicity; D019941:Cyclin-Dependent Kinase Inhibitor p16; D018076:DNA, Complementary; D016193:G1 Phase; D017353:Gene Deletion; D016147:Genes, Tumor Suppressor; D005910:Glioma / Q000235:genetics* / Q000473:pathology; D006801:Humans; D015376:Nimustine / Q000633:toxicity; D011994:Recombinant Proteins / Q000096:biosynthesis; D014162:Transfection; D014407:Tumor Cells, Cultured
chemical_list: D000970:Antineoplastic Agents; D002352:Carrier Proteins; D019941:Cyclin-Dependent Kinase Inhibitor p16; D018076:DNA, Complementary; D011994:Recombinant Proteins; D015376:Nimustine; D001374:Azacitidine; D002945:Cisplatin